Baillie Gifford - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 192 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$4,272
-18.2%
1860.0%0.00%
Q4 2022$5,223
+4.5%
1860.0%0.00%
Q3 2022$5,000
+25.0%
1860.0%0.00%
Q2 2022$4,000
-20.0%
1860.0%0.00%
Q1 2022$5,000
-16.7%
1860.0%0.00%
Q4 2021$6,000
-33.3%
1860.0%0.00%
Q3 2021$9,000
-10.0%
1860.0%0.00%
Q2 2021$10,0000.0%1860.0%0.00%
Q1 2021$10,000
+25.0%
186
+1.6%
0.00%
Q4 2020$8,000
-90.2%
183
-89.3%
0.00%
Q4 2019$82,000
-99.8%
1,709
-99.8%
0.00%
-100.0%
Q3 2019$35,113,000
-34.8%
1,083,694
+0.4%
0.04%
-29.8%
Q2 2019$53,862,000
-8.4%
1,079,829
+23.8%
0.06%
-10.9%
Q1 2019$58,822,000
+47.9%
872,225
+1.1%
0.06%
+23.1%
Q4 2018$39,779,000
-23.1%
862,715
+28.7%
0.05%
-7.1%
Q3 2018$51,705,000
-2.0%
670,443
+7.0%
0.06%
-1.8%
Q2 2018$52,779,000
+10.9%
626,603
+7.6%
0.06%
+1.8%
Q1 2018$47,607,000582,1410.06%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders